Accessed November 14, 2023
Click Here to Learn More Already have Community+ membership
We are closely following specific nutritional challenges that come with these medications so that our innovation can meet specific needs like nutrient management and muscle mass preservation, says the company of its focus on GLP-1 consumers
If I had a crystal ball, I think we're going to see a bunch of stuff that goes outside of weight and more into whats called impulse control. So far anecdotally we see reductions in alcohol and drug use, and I think well have the first large-scale, randomized trials for alcohol and drug use trials in higher-risk populations and a variety of impulse control indications
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis
This points to an issue that were seeing, which is people who are not overweight or obese taking these medications purely for cosmetic reasons, Dr